CompletedNot Applicable

New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER)

United States60 participantsStarted 2011-09

Plain-language summary

The PREFER Trial primary objective of the trial is to show how much radiation attenuation is provided by XPF in absolute and relative terms.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Interventional Radiologists practicing in Baptist Cardiac \& Vascular Institute * consecutive endovascular procedure requiring C-arm fluoroscopy Exclusion Criteria: * Interventional Neuroradiologists and Interventional Cardiologists will not be included in this study.

What they're measuring

Radiation attenuation in percentage (%) and in absolute terms (μSv/min)

Timeframe: The attenuation is assessed directly after each procedure (day 1)

Trial details

NCT IDNCT01450969

SponsorBaptist Health South Florida

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2011-11

View on ClinicalTrials.gov More Exposure trials